^
Association details:
Biomarker:CCDC69 overexpression
Cancer:Breast Cancer
Drug Class:Immunotherapy
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Title:

High expression of CCDC69 is correlated with immunotherapy response and protective effects on breast cancer

Published date:
10/12/2023
Excerpt:
The mRNA of CCDC69 was downregulated in breast cancer tissues compared with normal tissues. Higher CCDC69 expression was associated with a better breast cancer prognosis….Meanwhile, high CCDC69 expression can predict better immunotherapy responses when compared with low CCDC69 expression.